Pharmabalance
ActiveSummary
Pharmabalance has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54,183 and a net result of €51,016. Its solvency ranks better than 70% of 9,557 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
2026
10-02
NBB filing
Annual accounts filed
financial year 2025 · micro format
2024
17-12
Gazette deed
IncorporationAppointment: HUYBRECHT Paulien (director) · Founder · Registered office clause8 facts ▸
Gazette deed
Incorporation
Appointment: HUYBRECHT Paulien (director) · Founder · Registered office clause8 facts ▸
- Incorporation, 12-12-2024
- Founder, HUYBRECHT Paulien Jenny Rita
- Registered office clause, “9340 Lede,Keiberg 51” (deed in Dutch) (2 times)
- Founding capital
- Other provision, “uitwerking overgangsbepalingen, eenparig door comparant” (deed in Dutch)
- Board rule, 1, “vergadering” (deed in Dutch)
- Director appointment, HUYBRECHT Paulien (director (not named in the articles))
- Pre-incorporation commitments, “takeover”, 24-11-2024 (deed in Dutch)
Gazette deedNBB filing
1 of 1 deed read